Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

This talk will cover in vivo imaging findings on the nature of the dopaminergic alterations in patients with schizophrenia, recent data in bipolar psychosis, and the effects of antipsychotic treatment on dopamine synthesis capacity. Data on the glutamatergic regulation of this aspect of dopamine function will be presented, as well as new data on cannabinoid receptor alterations in first episode psychosis.